A Win–Win Solution in Oral Delivery of Lipophilic Drugs: Supersaturation via Amorphous Solid Dispersions Increases Apparent Solubility without Sacrifice of Intestinal Membrane Permeability

Molecular Pharmaceutics - Tập 9 Số 7 - Trang 2009-2016 - 2012
Jonathan M. Miller1, Avital Beig2, Robert Carr3, Julie K. Spence3, Arik Dahan2
1Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064, United States.
2Department#R#of Clinical Pharmacology,#R#School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University#R#of the Negev, Beer-Sheva 84105, Israel
3Global Pharmaceutical Research#R#and Development, Abbott Laboratories, Abbott Park, Illinois 60064,#R#United States

Tóm tắt

Từ khóa


Tài liệu tham khảo

Dahan A., 2009, AAPS J., 11, 740, 10.1208/s12248-009-9144-x

Yu L. X., 1996, Adv. Drug Delivery Rev., 19, 359, 10.1016/0169-409X(96)00009-9

Lennernas H., 1998, J. Pharm. Sci., 87, 403, 10.1021/js970332a

Amidon G. L., 1995, Pharm. Res., 12, 413, 10.1023/A:1016212804288

Lobenberg R., 2000, Eur. J. Pharm. Biopharm., 50, 3, 10.1016/S0939-6411(00)00091-6

Martinez M. N., 2002, J. Clin. Pharmacol., 42, 620, 10.1177/00970002042006005

Dahan A., 2010, Mol. Pharmaceutics, 7, 1827, 10.1021/mp100175a

Dahan A., 2012, Mol. Pharmaceutics, 9, 1847, 10.1021/mp300140h

Dahan A., 2008, J. Controlled Release, 129, 1, 10.1016/j.jconrel.2008.03.021

Lipinski C. A., 2001, Adv. Drug Delivery Rev., 46, 3, 10.1016/S0169-409X(00)00129-0

Porter C. J. H., 2007, Nat. Rev. Drug Discovery, 6, 231, 10.1038/nrd2197

10.1016/j.jconrel.2012.01.017

Dahan A., 2010, J. Pharm. Sci., 99, 2739, 10.1002/jps.22033

Miller J. M., 2011, Mol. Pharmaceutics, 8, 1848, 10.1021/mp200181v

Miller J. M., 2012, Int. J. Pharm., 430, 388, 10.1016/j.ijpharm.2012.03.017

Miller J. M., 2012, Mol. Pharmaceutics, 9, 581, 10.1021/mp200460u

Beig A., 2012, Eur. J. Pharm. Biopharm., 81, 386, 10.1016/j.ejpb.2012.02.012

Dahan A., 2012, AAPS J., 14, 244, 10.1208/s12248-012-9337-6

Gardner C. R., 2004, Nat. Rev. Drug Discovery, 3, 926, 10.1038/nrd1550

Hancock B. C., 2000, Pharm. Res., 17, 397, 10.1023/A:1007516718048

Hancock B. C., 1997, J. Pharm. Sci., 86, 1, 10.1021/js9601896

Friesen D. T., 2008, Mol. Pharmaceutics, 5, 1003, 10.1021/mp8000793

Gao Y., 2010, Mol. Pharmaceutics, 7, 1516, 10.1021/mp100157s

Law D., 2001, J. Pharm. Sci., 90, 1015, 10.1002/jps.1054

Law D., 2004, J. Pharm. Sci., 93, 563, 10.1002/jps.10566

Serajuddin A. T. M., 1999, J. Pharm. Sci., 88, 1058, 10.1021/js980403l

Curatolo W., 2009, Pharm. Res., 26, 1419, 10.1007/s11095-009-9852-z

Alonzo D., 2010, Pharm. Res., 27, 608, 10.1007/s11095-009-0021-1

Alonzo D. E., 2011, J. Pharm. Sci., 100, 3316, 10.1002/jps.22579

Miller J. M., 2009, J. Controlled Release, 137, 31, 10.1016/j.jconrel.2009.02.018

Wohnsland F., 2001, J. Med. Chem., 44, 923, 10.1021/jm001020e

Dahan A., 2009, Am. J. Physiol., 297, G371

Dahan A., 2009, Mol. Pharmaceutics, 6, 19, 10.1021/mp800088f

Dahan A., 2009, Pharm. Res., 26, 883, 10.1007/s11095-008-9789-7

Sutton S., 2001, AAPS PharmSci, 3, 1, 10.1208/ps030325